Document is current
Any future updates will be listed below
-
Authors
Haagdorens, Michel https://orcid.org/0000-0003-1568-556X
Edin, Elle https://orcid.org/0000-0001-8465-1764
Fagerholm, Per https://orcid.org/0000-0002-6767-4769
Groleau, Marc https://orcid.org/0000-0001-9291-6929
Shtein, Zvi
Ulčinas, Artūras https://orcid.org/0000-0003-2022-3116
Yaari, Amit
Samanta, Ayan
Cepla, Vytautas https://orcid.org/0000-0002-1433-3274
Liszka, Aneta
Tassignon, Marie-José https://orcid.org/0000-0001-8302-8006
Simpson, Fiona https://orcid.org/0000-0003-3534-050X
Shoseyov, Oded https://orcid.org/0000-0003-3340-9921
Valiokas, Ramūnas https://orcid.org/0000-0003-4807-9136
Pintelon, Isabel https://orcid.org/0000-0003-2901-4679
Ljunggren, Monika Kozak https://orcid.org/0000-0002-6116-1524
Griffith, May https://orcid.org/0000-0003-1222-6720
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
First Online: 6 August 2021
Declarations
:
: The Declaration of Helsinki guidelines were applied and were approved by the Antwerp University Hospital Ethical Committee (EC: 14/30/319) for use of human amniotic membrane. Animal experiments in rats and Göttingen minipigs were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and the Swedish Animal Welfare Ordinance and the Animal Welfare Act, after ethical approval was acquired from the local Linkoping ethical committee (Linköpings Djurförsöksetiska Nämnd).
: Dr. Oded Shoseyov is a founder and chief scientist at CollPlant which produces and markets tobacco-derived RHCI. Other authors have no competing interests.
